Metagil-GV2

Composition: Glimepiride 2 mg + Voglibose 0.2 mg + Metformin 500 mg SR 

Metagil GV2 is a higher-strength triple combination of Glimepiride 2 mg, Voglibose 0.2 mg, and Metformin 500 mg. This formulation provides strong and comprehensive control of Type 2 Diabetes by improving insulin secretion, slowing carbohydrate absorption, and improving insulin sensitivity throughout the day. It is suitable for patients requiring more potent glucose-lowering action, especially those with high post-meal sugar levels.

Uses:

• Advanced control of Type 2 Diabetes
• Management of high postprandial sugar levels
• Reduction of HbA1c
• For patients needing stronger therapy beyond dual medications

Side Effects:

• Low blood sugar
• Bloating, gas, abdominal discomfort
• Mild nausea or diarrhea
• Dizziness, sweating
• Rare: lactic acidosis

Other Details:

• Take just before meals for best effect
• Regular monitoring of sugar advised
• Avoid alcohol
• Not suitable for patients with severe renal issues